تكاليف إعادة العمل وعدم الامتثال في الأدوية المركبة (Compounding Rework & Compliance Failures)
Definition
Manual worksheet logging and expiry date assignment (per DHCC Standards § 3.10.12) are error-prone: technician writes batch date → calculates expiry based on guidelines (often inconsistent) → Pharmacist double-checks (inconsistent verification). Errors include: expiry date set incorrectly (too long or too short), missing or illegible batch identifier, Arabic labeling incomplete, ingredient quantities not verified. Result: batch cannot be dispensed, requires disposal (100% loss) or rework (20–40% additional cost). Search result [1] cites common registration delays include 'Non-compliance with packaging or Arabic labeling requirements'—implying labeling errors are frequent.
Key Findings
- Financial Impact: LOGIC estimate: 2–5% batch loss rate × average compounding batch value (AED 500–2,000/batch) = AED 10,000–100,000 annually in wasted material; plus rework labor (AED 2,000–10,000/month in repeat compounding)
- Frequency: Ongoing; 2–5% of compounded batches monthly
- Root Cause: Manual expiry date calculation (ambiguous guidelines); inconsistent verification; missing or incomplete Arabic labeling; unverified ingredient tracking
Why This Matters
This pain point represents a significant opportunity for B2B solutions targeting Retail Pharmacies.
Affected Stakeholders
Compounding technician, Pharmacist-in-Charge, Quality assurance officer
Deep Analysis (Premium)
Financial Impact
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Current Workarounds
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Get Solutions for This Problem
Full report with actionable solutions
- Solutions for this specific pain
- Solutions for all 15 industry pains
- Where to find first clients
- Pricing & launch costs
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.
Related Business Risks
غرامات عدم الامتثال لتوثيق الأدوية المركبة (MOHAP Documentation Compliance Fines)
فقدان القدرة الإنتاجية بسبب التوثيق اليدوي للأدوية المركبة (Compounding Documentation Bottleneck)
غرامات عدم الامتثال لنظام معلومات الصحة (NABIDH/EMR Integration Failures)
فقدان الإيرادات بسبب تأخير التسجيل والموافقة (Product Registration Delays & Market Entry Losses)
نقص المخزون والتناقضات في تسجيل المخدرات
هدر الأدوية منتهية الصلاحية
Request Deep Analysis
🇦🇪 Be first to access this market's intelligence